Silk sutures are common in surgeries, and silk-based
textiles are
widely used in clinical medicine on account of their great mechanical
properties and biodegradability. However, due to the lack of biocatalytic
activity, silk sutures show unsatisfactory anti-inflammatory properties
and healing speed. To address this constraint, we construct clinical
grade bioactive gold cluster–sutures through a heterojunction.
The antioxidant activity of bioactive gold cluster–sutures
is ∼160 times more than that of clinical sutures. Meanwhile,
the suture displays superb reactive oxygen species (ROS) scavenging,
superoxide dismutase-like (SOD-like, 5 times more than the silk suture),
and catalase-like (CAT-like) activities. The clusters assemble on
the surface of silk through hydrogen bonding, leading to a durable
catalytic and structural stability for 15 months without decay. Subsequently,
the suture significantly accelerates wound healing by exerting excellent
anti-inflammatory effects, improving neovascularization and collagen
deposition. Clinical grade bioactive gold clusters with high bioactivity,
stability, and biocompatibility hold promise for clinical translation
and pave the way for other implanted biomaterials from wound healing
to intelligent textiles.